Know Cancer

or
forgot password

A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy


Phase 3
18 Years
N/A
Not Enrolling
Both
Anemia

Thank you

Trial Information

A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy


This was a two stage, randomized, controlled study of cancer patients undergoing or planning
to undergo chemotherapy. After stage one, (where patients were exposed to an erythropoiesis
stimulating agent), patients were randomized to receive either IV iron sucrose or no iron
supplementation. Patients were then followed to safety and efficacy endpoints.


Inclusion Criteria:



- Histological Diagnosis of Cancer

- Hgb
- Ongoing or Planned Chemotherapy

- Body Weight >50kg

- Free of Active Infection

- Karnofsky Status 60% to 100%

Exclusion Criteria:

- Active infection

- Use of Multivitamins with iron within one week of entry

- Myelophthisic bone marrow involvement by tumor except hematologic malignancy

- Concurrent medical condition that would prevent compliance or jeopardize the health
of the patient

- Use of any IV iron products within two months of study entry

- Blood Transfusions

- Hypoplastic bone marrow failure state

- Acute Leukemia

- Myeloproliferative syndrome

- Uncontrolled hypertension

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Outcome Measure:

Change From Baseline to the Maximum Hemoglobin Level During Stage 2 (Week 9 Through Week 21).

Outcome Description:

The hemoglobin baseline was defined as the average of the last 2 hemoglobin values during stage 1 (through week 8).

Outcome Time Frame:

During Stage 2 (week 9 through week 21)

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

1VEN02023

NCT ID:

NCT00236951

Start Date:

February 2003

Completion Date:

December 2005

Related Keywords:

  • Anemia
  • Anemia
  • Cancer
  • Chemotherapy
  • Anemia

Name

Location